Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$477 Mln
Revenue (TTM)
$1,485 Mln
Net Profit (TTM)
$160 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
4.5
P/B Ratio
0.4
Industry P/E
--
EV/EBITDA
3.2
Div. Yield
2.5 %
Debt to Equity
0.5
Book Value
$16.1
EPS
$3.2
Face value
--
Shares outstanding
48,750,076
CFO
$1,971.56 Mln
EBITDA
$2,957.60 Mln
Net Profit
$1,342.18 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nu Skin Enterprises (NUS)
| -25.4 | -16.6 | -31.4 | -13.0 | -42.7 | -33.1 | -15.1 |
|
BSE Sensex
| -9.4 | -8.1 | -9.3 | 3.4 | 9.8 | 9.0 | 12.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Nu Skin Enterprises (NUS)
| 39.6 | -64.2 | -53.9 | -16.9 | -7.1 | 33.3 | -33.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nu Skin Enterprises (NUS)
|
7.2 | 476.8 | 1,485.2 | 160.2 | 14.2 | 22 | 4.5 | 0.4 |
| 1.2 | 161.9 | 300.8 | -9.5 | 3.9 | -16.8 | -- | 2.5 | |
| 87.5 | 71,209.5 | 20,382.0 | 2,132.0 | 15.4 | 1603 | 33.8 | 1,305.5 | |
| 19.9 | 923.1 | 2,167.9 | -38.2 | 2.9 | -2.5 | 179.6 | 0.6 | |
| 88.1 | 2,933.8 | 1,488.5 | 168.4 | 16.3 | 20.7 | 17.5 | 3.3 | |
| 1.3 | 803.3 | 423.0 | -9.3 | 3.8 | -1.1 | -- | 0.9 | |
| 146.7 | 352,594.1 | 85,259.0 | 16,466.0 | 18.6 | 31.1 | 22.3 | 6.7 | |
| 0.3 | 25.5 | 4.8 | 0.0 | -7.9 | -151.6 | -- | 0.0 | |
| 2.3 | 38.4 | 0.3 | -19.1 | -4,112.8 | -72.9 | -- | 1.0 | |
| 3.6 | 623.2 | 4,181.0 | -78.7 | -2.3 | -2.6 | -- | 0.9 |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC... LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. Read more
Co-Founder & Executive Chairman of the Board
Mr. Steven J. Lund
Co-Founder & Executive Chairman of the Board
Mr. Steven J. Lund J.D.
Headquarters
Provo, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Nu Skin Enterprises Inc (NUS) is $7.18 (NYSE) as of 18-Mar-2026 16:00 EDT. Nu Skin Enterprises Inc (NUS) has given a return of -42.72% in the last 3 years.
The P/E ratio of Nu Skin Enterprises Inc (NUS) is 4.47 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
3.00
|
0.60
|
|
2024
|
-2.34
|
0.53
|
|
2023
|
111.80
|
1.17
|
|
2022
|
20.03
|
2.34
|
|
2021
|
17.51
|
2.82
|
The 52-week high and low of Nu Skin Enterprises Inc (NUS) are Rs 14.62 and Rs 5.32 as of 19-Mar-2026.
Nu Skin Enterprises Inc (NUS) has a market capitalisation of $ 477 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Nu Skin Enterprises Inc (NUS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.09
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.